Glycopyrrolate Tablet
FDA Label NDC 49884-066

29 label sections · Submitted to the FDA by Par Health Usa, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Par Health Usa, Llc for the product Glycopyrrolate (NDC 49884-066). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2.1 important dosing information, 2.2 recommended dosage, 3 dosage forms and strengths, 4 contraindications, 5.1 precipitation of acute glaucoma, 5.2 partial or complete mechanical intestinal obstruction, 5.3 gastrointestinal adverse reactions due to decreased gastrointestinal motility, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.